Loading clinical trials...
Loading clinical trials...
The purpose of this study is to define the recommended dose of BMS-582664 that could be safely combined with 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) or 5-fluorouracil, leucovorin, and oxa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bristol-Myers Squibb
NCT06663319 · Colorectal Neoplasms, Gastrointestinal Neoplasms
NCT07222800 · Intestinal Neoplasms, Gastrointestinal Neoplasms, and more
NCT01750619 · Gastrointestinal Neoplasms, Benign Neoplasm of Intestinal Tract
NCT04907643 · Cancer Pain, Visceral Pain, and more
NCT06048146 · Lymph Node Metastasis, Cancer of Rectum and Anus, and more
Local Institution
Little Rock, Arkansas
Local Institution
Los Angeles, California
Local Institution
Washington D.C., District of Columbia
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions